𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open trial of buspirone in the treatment of attention-deficit disorder

✍ Scribed by Helmut Niederhofer

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
48 KB
Volume
18
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Objective

Medications such as clonidine have been shown to facilitate calming, to enhance frustration tolerance, and to reduce aggression in attention deficit disorder (ADD) patients. The use of buspirone was studied as an alternative because of its longer excretion half‐life, decreased sedative side effects and more selective binding profile.

Method

Eight psychiatric outpatients diagnosed with ADD were rated at baseline and while taking buspirone to determine its efficacy as a treatment for ADD. Comparisons of Wender‐Utah ratings within subject were used to measure behavioural changes in the subjects.

Results

During buspirone treatment, the patients' mean scores improved significantly overall and in hyperactivity, inattention and immaturity factors.

Conclusions

This preliminary study indicates that buspirone might be a beneficial and useful treatment of ADD, reducing hyperactive behaviours and enabling greater attentional ability with minimal side effects. Copyright Β© 2003 John Wiley & Sons, Ltd.

πŸ“œ SIMILAR VOLUMES

Duloxetine in the treatment of adolescen
Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study
✍ Javad Mahmoudi-Gharaei; Nasrin Dodangi; Mehdi Tehrani-Doost; Toktam Faghihi πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

Objective The main aim of this study was to explore the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in the treatment of adolescents with attention deficit/hyperactivity disorder (ADHD). Methods Seventeen adolescents aged 11-18 years, diagnosed with ADHD, par

Double-blind controlled trial of venlafa
Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder
✍ Shahrokh Amiri; Sara Farhang; Mohammad Ali Ghoreishizadeh; Ayyoub Malek; Soleima πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 161 KB

Background Attention deficit/hyperactivity disorder (ADHD) is one of the most common mental disorders beginning in childhood that may continue to adulthood. The purpose of this study was to evaluate the possible therapeutic effect of venlafaxine in adults with ADHD. Methods In a double-blind setting

Old and new controversies in the alterna
Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder
✍ Rojas, Neal L. ;Chan, Eugenia πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 169 KB

## Abstract Use of complementary and alternative medicine (CAM) for treatment of attention‐deficit hyperactivity disorder (ADHD) has become widespread in both referral and primary care populations. We review the purported mechanism of action and available evidence for selected CAM therapies for ADH